Do initial responses to drugs predict future use or abuse?

Neuroscience and Biobehavioral Reviews

Volumn 36, Issue 6, 2012, Pages 1565-1576

  de Wit, Harriet ^a   Phillips, Tamara J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acute drug effects; Drug abuse; Human; Initiation; Nonhuman; Predictors; Risk

Indexed keywords

ACETALDEHYDE; ALCOHOL; ALCOHOL DEHYDROGENASE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CAFFEINE; CANNABINOID RECEPTOR; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; CYTOCHROME P450 2A5; DIAMORPHINE; HYDROCORTISONE; INHALATION ANESTHETIC AGENT; METHYLPHENIDATE; NICOTINE; OPIATE; PROLACTIN; PSYCHEDELIC AGENT; TOBACCO SMOKE;

ADAPTATION; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; AVERSION; CANNABIS ADDICTION; CIGARETTE SMOKING; COGNITION; DRINKING BEHAVIOR; DRUG ABUSE; DRUG DEPENDENCE; DRUG RESPONSE; DRUG SENSITIVITY; DRUG USE; HUMAN; LEARNING; MENTAL FUNCTION; NONHUMAN; PERSONAL EXPERIENCE; PHYSIOLOGICAL STRESS; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIZATION; SHORT TERM MEMORY; STIMULUS RESPONSE; UNPLEASANT SENSATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDIVIDUALITY; RISK FACTORS; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 84861214593     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.04.005     Document Type: Review

References (211)

1. Agabio R., et al. Alcohol stimulates motor activity in selectively bred Sardinian alcohol-preferring (sP), but not in Sardinian alcohol-nonpreferring (sNP), rats. Alcohol 2001, 23:123-126.
2. 2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003, 28:1694-1702.
3. Amin N., et al. Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Molecular Psychiatry 2011, 10.1038/mp.2011.101.
4. Amit Z., et al. Possible involvement of acetaldehyde, norepinephrine and their tetrahydroisoquinoline derivatives in the regulation of ethanol self-administration. Drug and Alcohol Dependence 1977, 2:495-500.
5. APA Diagnostic and Statistical Manual of Mental Disorders: DSM-IV 1994, American Psychiatric Association, Washington, DC.
6. Audrain-McGovern J., et al. The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics 2007, 119:e264-e274.
7. Balster R.L., Bigelow G.E. Guidelines and methodological reviews concerning drug abuse liability assessment. Drug and Alcohol Dependence 2003, 70:S13-S40.
8. Bass C.E., et al. SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study. Pharmacology Biochemistry and Behavior 2002, 74:31-40.
9. Belknap J.K., et al. Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiology and Behavior 1989, 46:69-74.
10. Belknap J.K., et al. Voluntary consumption of morphine in 15 inbred mouse strains. Psychopharmacology 1993, 112:352-358.
11. Benowitz N.L., Jacob P. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clinical Pharmacology and Therapeutics 1994, 56:483-493.
12. Bergstrom H.C., et al. Reverse selection for differential response to the locomotor stimulant effects of ethanol provides evidence for pleiotropic genetic influence on locomotor response to other drugs of abuse. Alcoholism, Clinical and Experimental Research 2003, 27:1535-1547.
13. Besheer J., et al. The effects of repeated corticosterone exposure on the interoceptive effects of alcohol in rats. Psychopharmacology 2012, 220:809-822.
14. Bevins R.A., et al. Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats. Behavioural Pharmacology 1997, 8:113-123.
15. Bieber C.M., et al. Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Experimental and Clinical Psychopharmacology 2008, 16:429-434.
16. Boehm S.L., et al. Sensitivity to ethanol-induced motor incoordination in FAST and SLOW selectively bred mice. Pharmacology Biochemistry and Behavior 2000, 66:241-247.
17. Boulenger J.P., et al. Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. Archives of General Psychiatry 1984, 41:1067-1071.
18. Boyle A.E., Gill K.J. Genetic analysis of the psychostimulant effects of nicotine in chromosome substitution strains and F2 crosses derived from A/J and C57BL/6J progenitors. Mammalian Genome 2009, 20:34-42.
19. Broadbent J., et al. Ethanol-induced conditioned taste aversion in 15 inbred mouse strains. Behavioral Neuroscience 2002, 116:138-148.
20. Brower V.G., et al. Rat strain differences in nicotine self-administration using an unlimited access paradigm. Brain Research 2002, 930:12-20.
21. Buchmann A.F., et al. Early smoking onset may promise initial pleasurable sensations and later addiction. Addiction Biology 2011, 10.1111/j.1369-1600.2011.00377.x.
22. Caggiula A.R., et al. The role of nicotine in smoking: a dual-reinforcement model. Nebraska Symposium on Motivation 2009, 55:91-109.
23. Cailhol S., Mormede P. Conditioned taste aversion and alcohol drinking: strain and gender differences. Journal of Studies on Alcohol 2002, 63:91-99.
24. Carter B., et al. A meta-analytic review of the CYP2A6 genotype and smoking behavior. Nicotine and Tobacco Research 2004, 6:221-227.
25. Carter L.P., Griffiths R.R. Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependence 2009, 105(Suppl. 1):S14-S25.
26. Chait L.D., Perry J.L. Factors influencing self-administration of, and subjective response to, placebo marijuana. Behavioural Pharmacology 1992, 3:545-552.
27. Chait L.D. Factors influencing the reinforcing and subjective effects of d-amphetamine in humans. Behavioural Pharmacology 1993, 4:191-199.
28. Changeux J.P. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nature Reviews Neuroscience 2010, 11:389-401.
29. Charney D.S., et al. Increased anxiogenic effects of caffeine in panic disorders. Archives of General Psychiatry 1985, 42:233-243.
30. Chaudhri N., et al. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology 2006, 184:353-366.
31. Chen X., et al. Sensations from initial exposure to nicotine predicting adolescent smoking in China: a potential measure of vulnerability to nicotine. Nicotine and Tobacco Research 2003, 5:455-463.
32. Chester J.A., et al. High- and low-alcohol-preferring mice show differences in conditioned taste aversion to alcohol. Alcoholism, Clinical and Experimental Research 2003, 27:12-18.
33. Childs E., et al. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2008, 33:2791-2800.
34. Chutuape M.A., de Wit H. Relationship between subjective effects and drug preferences: ethanol and diazepam. Drug and Alcohol Dependence 1994, 34:243-251.
35. Cloninger C.R., et al. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. Archives of General Psychiatry 1981, 38:861-868.
36. Colombo G., et al. Different sensitivity to ethanol in alcohol-preferring sP and -nonpreferring sNP rats. Alcoholism, Clinical and Experimental Research 2000, 24:1603-1608.
37. Comer S.D., et al. Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers. Psychopharmacology 2010, 208:45-55.
38. Conrod P.J., et al. Reliability and validity of alcohol-induced heart rate increase as a measure of sensitivity to the stimulant properties of alcohol. Psychopharmacology 2001, 157:20-30.
39. Cornelis M.C., et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genetics 2011, 7:e1002033.
40. Corrigall W.A., Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 1989, 99:473-478.
41. Crabbe J.C., et al. Mice genetically selected for differences in open-field activity after ethanol. Pharmacology Biochemistry and Behavior 1987, 27:577-581.
42. Crabbe J.C., et al. Alcohol-related genes: contributions from studies with genetically engineered mice. Addiction Biology 2006, 11:195-269.
43. Crabbe J.C., et al. The complexity of alcohol drinking: studies in rodent genetic models. Behavior Genetics 2010, 40:737-750.
44. Cummings J.A., et al. Effects of a selectively bred novelty-seeking phenotype on the motivation to take cocaine in male and female rats. Biology of Sex Differences 2011, 2:3.
45. Darmani N.A. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55,212-2. European Journal of Pharmacology 2001, 430:49-58.
46. Davidson E.S., et al. Variability in subjective responses to cocaine: initial experiences of college students. Addictive Behaviors 1993, 18:445-453.
47. Davidson E.S., Schenk S. Variability in subjective responses to marijuana: initial experiences of college students. Addictive Behaviors 1994, 19:531-538.
48. Davis B.A., et al. The effects of novelty-seeking phenotypes and sex differences on acquisition of cocaine self-administration in selectively bred high-responder and low-responder rats. Pharmacology Biochemistry and Behavior 2008, 90:331-338.
49. de Wit H., et al. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug and Alcohol Dependence 1986, 16:341-360.
50. de Wit H., et al. The reinforcing properties of amphetamine in overweight subjects and subjects with depression. Clinical Pharmacology and Therapeutics 1987, 42:127-136.
51. de Wit H., Griffiths R.R. Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug and Alcohol Dependence 1991, 28:83-111.
52. de Wit H., Bodker B. Personality and drug preferences in normal volunteers. International Journal of the Addictions 1994, 29:1617-1630.
53. de Wit H. Individual differences in acute effects of drugs in humans: their relevance to risk for abuse. NIDA Research Monograph 1998, 169:176-187.
54. Deminiere J.M., et al. Experimental approach to individual vulnerability to psychostimulant addiction. Neuroscience and Biobehavioral Reviews 1989, 13:141-147.
55. DiFranza J.R., et al. Recollections and repercussions of the first inhaled cigarette. Addictive Behaviors 2004, 29:261-272.
56. DiFranza J.R., et al. Susceptibility to nicotine dependence: the development and assessment of nicotine dependence in youth 2 study. Pediatrics 2007, 120:e974-e983.
57. Dubreucq S., et al. Cannabinoid type 1 receptors located on single-minded 1-expressing neurons control emotional behaviors. Neuroscience 2012, 204:230-244.
58. Edenberg H.J. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Research and Health 2007, 30:5-13.
59. Ehlers C.L., Schuckit M.A. EEG fast frequency activity in the sons of alcoholics. Biological Psychiatry 1990, 27:631-641.
60. Eissenberg T., Balster R.L. Initial tobacco use episodes in children and adolescents: current knowledge, future directions. Drug and Alcohol Dependence 2000, 59(Suppl. 1):S41-S60.
61. El Yacoubi M., et al. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. British Journal of Pharmacology 2000, 129:1465-1473.
62. El Yacoubi M., et al. Reduced appetite for caffeine in adenosine A(2A) receptor knockout mice. European Journal of Pharmacology 2005, 519:290-291.
63. Elmer G.I., et al. Opioid operant self-administration, analgesia, stimulation and respiratory depression in mu-deficient mice. Psychopharmacology 1995, 117:23-31.
64. Elmer G.I., et al. Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration. Psychopharmacology 2010, 208:309-321.
65. Eng M.Y., et al. The level of response to alcohol in daughters of alcoholics and controls. Drug and Alcohol Dependence 2005, 79:83-93.
66. Everitt B.J., et al. Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 2008, 363:3125-3135.
67. Fattore L., et al. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology 2001, 156:410-416.
68. Fergusson D.M., et al. Early reactions to cannabis predict later dependence. Archives of General Psychiatry 2003, 60:1033-1039.
69. Files F.J., et al. Initiation of ethanol self-administration by the sucrose-substitution method with HAS and LAS rats. Alcoholism, Clinical and Experimental Research 1996, 20:677-681.
70. Fischman M.W., Foltin R.W. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. British Journal of Addiction 1991, 86:1563-1570.
71. Flagel S.B., et al. An animal model of genetic vulnerability to behavioral disinhibition and responsiveness to reward-related cues: implications for addiction. Neuropsychopharmacology 2010, 35:388-400.
72. Frary C.D., et al. Food sources and intakes of caffeine in the diets of persons in the United States. Journal of the American Dietetic Association 2005, 105:110-113.
73. Froehlich J.C., et al. Differences in response to the aversive properties of ethanol in rats selectively bred for oral ethanol preference. Pharmacology Biochemistry and Behavior 1988, 31:215-222.
74. Garcia-Fuster M.J., et al. Impact of cocaine on adult hippocampal neurogenesis in an animal model of differential propensity to drug abuse. European Journal of Neuroscience 2010, 31:79-89.
75. Gill K.J., Boyle A.E. Genetic basis for the psychostimulant effects of nicotine: a quantitative trait locus analysis in AcB/BcA recombinant congenic mice. Genes, Brain and Behavior 2005, 4:401-411.
76. Gordh A.H., et al. Stress and consumption of alcohol in humans with a type 1 family history of alcoholism in an experimental laboratory setting. Pharmacology Biochemistry and Behavior 2011, 99:696-703.
77. Gordon T.L., et al. P and NP rats respond differently to the discriminative stimulus effects of nicotine. Pharmacology Biochemistry and Behavior 1993, 45:305-308.
78. Grahame N.J., et al. Ethanol locomotor sensitization, but not tolerance correlates with selection for alcohol preference in high- and low-alcohol preferring mice. Psychopharmacology 2000, 151:252-260.
79. Grant B.F. The impact of a family history of alcoholism on the relationship between age at onset of alcohol use and DSM-IV alcohol dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. Alcohol Health and Research World 1998, 22:144-147.
80. Griffiths R.R., Woodson P.P. Reinforcing effects of caffeine in humans. Journal of Pharmacology and Experimental Therapeutics 1988, 246:21-29.
81. Haberstick B.C., et al. Common and drug-specific genetic influences on subjective effects to alcohol, tobacco and marijuana use. Addiction 2011, 106:215-224.
82. Haertzen C.A., et al. Reinforcements from the first drug experience can predict later drug habits and/or addiction: results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine. Drug and Alcohol Dependence 1983, 11:147-165.
83. Hart A.B., de Wit H., Palmer A.A. Genetic factors modulating the response to stimulant drugs in humans. Current Topics in Behavioral Neurosciences 2012, [Epub ahead of print] PMID: 22261702 [PubMed-as supplied by publisher].
84. Hendler R.A., et al. Stimulant and sedative effects of alcohol. Current Topics in Behavioral Neurosciences 2011, 10.1007/7854_2011_135.
85. Ho M.K., Tyndale R.F. Overview of the pharmacogenomics of cigarette smoking. Pharmacogenomics Journal 2007, 7:81-98.
86. Hodge C.W., et al. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nature Neuroscience 1999, 2:997-1002.
87. Hojsted J., Sjogren P. Addiction to opioids in chronic pain patients: a literature review. European Journal of Pain 2007, 11:490-518.
88. Holdstock L., de Wit H. Individual differences in responses to ethanol and d-amphetamine: a within-subject study. Alcoholism, Clinical and Experimental Research 2001, 25:540-548.
89. Horowitz G.P., Whitney G. Alcohol-induced conditioned aversion: genotypie specificity in mice (Mus musculus). Journal of Comparative and Physiological Psychology 1975, 89:340-346.
90. Horowitz G.P., et al. Morphine ingestion: genetic control in mice. Psychopharmacology 1977, 52:119-122.
91. Hu M.C., et al. Epidemiology and correlates of daily smoking and nicotine dependence among young adults in the United States. American Journal of Public Health 2006, 96:299-308.
92. Isse T., et al. Diminished alcohol preference in transgenic mice lacking aldehyde dehydrogenase activity. Pharmacogenetics 2002, 12:621-626.
93. Isse T., et al. Aldehyde dehydrogenase 2 gene targeting mouse lacking enzyme activity shows high acetaldehyde level in blood, brain, and liver after ethanol gavages. Alcoholism, Clinical and Experimental Research 2005, 29:1959-1964.
94. Jasinski D.R. History of abuse liability testing in humans. British Journal of Addiction 1991, 86:1559-1562.
95. Johanson C.E., Uhlenhuth E.H. Drug preference and mood in humans: d-amphetamine. Psychopharmacology 1980, 71:275-279.
96. 1-receptor antagonist rimonabant. Neuropsychopharmacology 2008, 33:2870-2877.
97. Kamens H.M., et al. Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes, Brain and Behavior 2005, 4:110-125.
98. Kandel D.B., et al. On the development of nicotine dependence in adolescence. Drug and Alcohol Dependence 2007, 91:26-39.
99. Karahanian E., et al. Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects. Alcoholism, Clinical and Experimental Research 2011, 35:606-612.
100. Kim K.S., et al. Mice lacking adenylyl cyclase type 5 (AC5) show increased ethanol consumption and reduced ethanol sensitivity. Psychopharmacology 2011, 215:391-398.
101. Kirk J.M., et al. Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacology Biochemistry and Behavior 1998, 59:287-293.
102. Kollins S.H., et al. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacology Biochemistry and Behavior 2001, 68:611-627.
103. Krimmer E.C. Biphasic effects of ethanol tested with drug discrimination in HAD and LAD rats. Pharmacology Biochemistry and Behavior 1992, 43:1233-1240.
104. Krimmer E.C., Schechter M.D. HAD and LAD rats respond differently to stimulating effect but not discriminative effects of ethanol. Alcohol 1992, 9:71-74.
105. Kurtz D.L., et al. Genetic differences in tolerance and sensitization to the sedative/hypnotic effects of alcohol. Pharmacology Biochemistry and Behavior 1996, 53:585-591.
106. Lambert N.M., et al. Subjective responses to initial experience with cocaine: an exploration of the incentive-sensitization theory of drug abuse. Addiction 2006, 101:713-725.
107. Lasagna L., et al. Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts. The Journal of the American Medical Association 1955, 157:1006-1020.
108. Le Strat Y., et al. First positive reactions to cannabis constitute a priority risk factor for cannabis dependence. Addiction 2009, 104:1710-1717.
109. Lecca D., et al. Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration. Psychopharmacology 2006, 188:63-74.
110. Lee M.A., et al. Anxiogenic effects of caffeine on panic and depressed patients. American Journal of Psychiatry 1988, 145:632-635.
111. Lott D.C., et al. Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 2005, 30:602-609.
112. Lumeng L., et al. Different sensitivities to ethanol in alcohol-preferring and -nonpreferring rats. Pharmacology Biochemistry and Behavior 1982, 16:125-130.
113. Malaiyandi V., et al. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Molecular Psychiatry 2006, 11:400-409.
114. Mandt B.H., et al. Individual differences in cocaine-induced locomotor activity in male Sprague-Dawley rats and their acquisition of and motivation to self-administer cocaine. Psychopharmacology 2008, 201:195-202.
115. Mandt B.H., et al. Acquisition of cocaine self-administration in male Sprague-Dawley rats: effects of cocaine dose but not initial locomotor response to cocaine. Psychopharmacology 2012, 219:1089-1097.
116. Mantsch J.R., et al. Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent. Psychopharmacology 2001, 157:31-39.
117. Manubay J.M., et al. Prescription drug abuse: epidemiology, regulatory issues, chronic pain management with narcotic analgesics. Primary Care; Clinics in Office Practice 2011, 38:71-90. vi.
118. Marks M.J., et al. Genetic influences on nicotine responses. Pharmacology Biochemistry and Behavior 1989, 33:667-678.
119. Martelle J.L., Nader M.A. A within-subject assessment of the discriminative stimulus and reinforcing effects of self-administered cocaine in rhesus monkeys. Psychopharmacology 2009, 203:343-353.
120. Maxwell C.R., et al. Acetate causes alcohol hangover headache in rats. PLoS One 2010, 5:e15963.
121. Maxwell J.C. The prescription drug epidemic in the United States: a perfect storm. Drug and Alcohol Review 2011, 30:264-270.
122. McAuliffe W.E. A second look at first effects: the subjective effects of opiates on nonaddicts. Journal of Drug Issues 1975, 5:369-399.
123. McGregor I.S., et al. Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacology Biochemistry and Behavior 1996, 53:657-664.
124. McMillan D.E., Li M. Lack of difference between HAD and LAD rats in the stimulus generalization of ethanol to nicotine. Behavioural Pharmacology 1999, 10:809-812.
125. McMillan D.E., et al. Differences between alcohol-preferring and alcohol-nonpreferring rats in ethanol generalization. Pharmacology Biochemistry and Behavior 1999, 64:415-419.
126. McMillan D.E., Li M. LAD rats learn a three-key drug discrimination more rapidly and achieve a higher level of performance than HAD rats. Behavioural Pharmacology 2001, 12:545-548.
127. Mendizabal V., et al. Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice. Neuropsychopharmacology 2006, 31:1957-1966.
128. 1 dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates. Journal of Pharmacology and Experimental Therapeutics 2000, 292:952-959.
129. Mitchell S.H., et al. Interaction of expectancy and the pharmacological effects of d-amphetamine: subjective effects and self-administration. Psychopharmacology 1996, 125:371-378.
130. Moss H.B., et al. Subtypes of alcohol dependence in a nationally representative sample. Drug and Alcohol Dependence 2007, 91:149-158.
131. Murray J.E., Bevins R.A. Cannabinoid conditioned reward and aversion: behavioral and neural processes. ACS Chemical Neuroscience 2010, 1:265-278.
132. Naassila M., et al. Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A(2A) receptors. Journal of Neuroscience 2002, 22:10487-10493.
133. Newlin D.B., Thomson J.B. Alcohol challenge with sons of alcoholics: a critical review and analysis. Psychological Bulletin 1990, 108:383-402.
134. Newlin D.B., Renton R.M. High risk groups often have higher levels of alcohol response than low risk: the other side of the coin. Alcoholism, Clinical and Experimental Research 2010, 34:199-202. (Author reply 203-195).
135. Newton P.M., et al. Increased response to morphine in mice lacking protein kinase C epsilon. Genes, Brain and Behavior 2007, 6:329-338.
136. O'Dell L.E., Khroyan T.V. Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans?. Pharmacology Biochemistry and Behavior 2009, 91:481-488.
137. Overstreet D.H. Differential effects of nicotine in inbred and selectively bred rodents. Behavior Genetics 1995, 25:179-185.
138. Ozburn A.R., et al. Behavioral differences between C57BL/6J×FVB/NJ and C57BL/6J×NZB/B1NJ F1 hybrid mice: relation to control of ethanol intake. Behavior Genetics 2010, 40:551-563.
139. Paivarinta P., Korpi E.R. Voluntary ethanol drinking increases locomotor activity in alcohol-preferring AA rats. Pharmacology Biochemistry and Behavior 1993, 44:127-132.
140. Panagis G., et al. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. Current Drug Abuse Reviews 2008, 1:350-374.
141. Panlilio L.V., et al. Cocaine self-administration increased by compounding discriminative stimuli. Psychopharmacology 1996, 125:202-208.
142. Perkins K.A., et al. Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation seeking. Experimental and Clinical Psychopharmacology 2000, 8:462-471.
143. Perkins K.A., et al. Reinforcing effects of nicotine as a function of smoking status. Experimental and Clinical Psychopharmacology 2001, 9:243-250.
144. Perkins K.A., et al. Association of retrospective early smoking experiences with prospective sensitivity to nicotine via nasal spray in nonsmokers. Nicotine and Tobacco Research 2008, 10:1335-1345.
145. Phillips T.J., Crabbe J.C. Behavioral studies of genetic differences in alcohol action. The Genetic Basis of Alcohol and Drug Actions 1991, 25-104. Plenum Press, New York. J.C. Crabbe, R.A. Harris (Eds.).
146. Phillips T.J., et al. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behavioral Neuroscience 1994, 108:789-803.
147. Phillips T.J., et al. Effects of acute and repeated ethanol exposures on the locomotor activity of BXD recombinant inbred mice. Alcoholism, Clinical and Experimental Research 1995, 19:269-278.
148. Phillips T.J., et al. Forward, relaxed, and reverse selection for reduced and enhanced sensitivity to ethanol's locomotor stimulant effects in mice. Alcoholism, Clinical and Experimental Research 2002, 26:593-602.
149. Phillips T.J., et al. Genetic correlational analyses of ethanol reward and aversion phenotypes in short-term selected mouse lines bred for ethanol drinking or ethanol-induced conditioned taste aversion. Behavioral Neuroscience 2005, 119:892-910.
150. Piazza P.V., et al. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
151. Pierre P.J., Vezina P. Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug. Psychopharmacology 1997, 129:277-284.
152. Quintanilla M.E. Effect of low doses of ethanol on spontaneous locomotor activity in UChB and UChA rats. Addiction Biology 1999, 4:443-448.
153. Quintanilla M.E., et al. Differences in sensitivity to the aversive effects of ethanol in low-alcohol drinking (UChA) and high-alcohol drinking (UChB) rats. Alcohol 2001, 23:177-182.
154. Riebe C.J., Wotjak C.T. Endocannabinoids and stress. Stress 2011, 14:384-397.
155. 1 receptors determine effects of caffeine on total fluid intake but not caffeine appetite. European Journal of Pharmacology 2007, 555:174-177.
156. Ripley T.L., et al. Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 2002, 43:1258-1268.
157. Risinger F.O., Cunningham C.L. Genetic differences in ethanol-induced hyperglycemia and conditioned taste aversion. Life Sciences 1992, 50:PL113-PL118.
158. Risinger F.O., et al. Motivational properties of ethanol in mice selectively bred for ethanol-induced locomotor differences. Psychopharmacology 1994, 116:207-216.
159. Risinger F.O., Cunningham C.L. Ethanol-induced conditioned taste aversion in BXD recombinant inbred mice. Alcoholism, Clinical and Experimental Research 1998, 22:1234-1244.
160. Risner M.E., Goldberg S.R. A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. Journal of Pharmacology and Experimental Therapeutics 1983, 224:319-326.
161. Robinson S.F., et al. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology 1996, 124:332-339.
162. Rodd Z.A., et al. Low-dose stimulatory effects of ethanol during adolescence in rat lines selectively bred for high alcohol intake. Alcoholism, Clinical and Experimental Research 2004, 28:535-543.
163. Rush C.R., et al. Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. Journal of Clinical Psychopharmacology 2001, 21:273-286.
164. Sannerud C.A., et al. The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys. European Journal of Pharmacology 1994, 271:461-469.
165. Schechter M.D. Locomotor activity but not conditioned place preference is differentially affected by a moderate dose of ethanol administered to P and NP rats. Alcohol 1992, 9:185-188.
166. Schuckit M.A. Relationship between the course of primary alcoholism in men and family history. Journal of Studies on Alcohol 1984, 45:334-338.
167. Schuckit M.A. Subjective responses to alcohol in sons of alcoholics and control subjects. Archives of General Psychiatry 1984, 41:879-884.
168. Schuckit M.A. Genetics and the risk for alcoholism. The Journal of the American Medical Association 1985, 254:2614-2617.
169. Schuckit M.A. Ethanol-induced changes in body sway in men at high alcoholism risk. Archives of General Psychiatry 1985, 42:375-379.
170. Schuckit M.A. Biological vulnerability to alcoholism. Journal of Consulting and Clinical Psychology 1987, 55:301-309.
171. Schuckit M.A., et al. Plasma cortisol levels following ethanol in sons of alcoholics and controls. Archives of General Psychiatry 1987, 44:942-945.
172. Schuckit M.A., et al. Serum prolactin levels in sons of alcoholics and control subjects. American Journal of Psychiatry 1987, 144:854-859.
173. Schuckit M.A. Reactions to alcohol in sons of alcoholics and controls. Alcoholism, Clinical and Experimental Research 1988, 12:465-470.
174. Schuckit M.A., Gold E.O. A simultaneous evaluation of multiple markers of ethanol/placebo challenges in sons of alcoholics and controls. Archives of General Psychiatry 1988, 45:211-216.
175. Schuckit M.A. Low level of response to alcohol as a predictor of future alcoholism. American Journal of Psychiatry 1994, 151:184-189.
176. Seale T.W., Carney J.M. Genetic determinants of susceptibility to the rewarding and other behavioral actions of cocaine. Journal of Addictive Diseases 1991, 10:141-162.
177. Serrano A., Parsons L.H. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. Pharmacology and Therapeutics 2011, 132:215-241.
178. Shabani S., et al. Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intake. Genes, Brain and Behavior 2011, 10:625-636.
179. Shabani S., et al. A genetic animal model of differential sensitivity to methamphetamine reinforcement. Neuropharmacology 2012, 62:2169-2177.
180. Shabani S., et al. Profound reduction in sensitivity to the aversive effects of methamphetamine in mice bred for high methamphetamine intake. Neuropharmacology 2012, 62:1134-1141.
181. Shen E.H., et al. Correlated responses to selection in FAST and SLOW mice: effects of ethanol on ataxia, temperature, sedation, and withdrawal. Alcoholism, Clinical and Experimental Research 1996, 20:688-696.
182. Siu E.C., et al. Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5. Psychopharmacology 2006, 184:401-408.
183. Sora I., et al μ opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo μ receptor reserve. Neuropsychopharmacology 2001, 25:41-54.
184. Spuhler K., Deitrich R.A. Correlative analysis of ethanol-related phenotypes in rat inbred strains. Alcoholism, Clinical and Experimental Research 1984, 8:480-484.
185. Stephens D.N., et al. The challenge of studying parallel behaviors in humans and animal models. Current Topics in Behavioral Neurosciences 2011, 10.1007/7854_2011_133.
186. Stern K.N., et al. Reinforcing and subjective effects of caffeine in normal human volunteers. Psychopharmacology 1989, 98:81-88.
187. Stolerman I.P., et al. Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology 1999, 141:297-306.
188. Sulem P., et al. Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Human Molecular Genetics 2001, 20:2071-2077.
189. Sziraki, et al. Differences in nicotine-induced dopamine release and nicotine pharmacokinetics between Lewis and Fischer 344 rats. Neurochemical Research 2001, 26:609-617.
190. Tagliabracci C.E., Singh S.M. Genetic regulation of gene-specific mRNA by ethanol in vivo and its possible role in ethanol preference in a cross with RI lines in mice. Biochemical Genetics 1996, 34:219-238.
191. Tanda G., et al. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nature Neuroscience 2000, 3:1073-1074.
192. Tanda G., Goldberg S.R. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology 2003, 169:115-134.
193. Thiele T.E., et al. High ethanol consumption and low sensitivity to ethanol-induced sedation in protein kinase A-mutant mice. Journal of Neuroscience 2000, 20:RC75.
194. 6 nicotinic receptor genes. Pharmacogenetics 2002, 12:197-208.
195. 7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine and Tobacco Research 2004, 6:145-158.
196. Tuesta L.M., et al. Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochemical Pharmacology 2011, 82:984-995.
197. Uhde T.W., et al. Caffeine: relationship to human anxiety, plasma MHPG and cortisol. Psychopharmacology Bulletin 1984, 20:426-430.
198. Varvel S.A., et al. Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine. Psychopharmacology 2007, 193:511-519.
199. 2 receptors. Journal of Pharmacology and Experimental Therapeutics 1999, 291:409-415.
200. Wagner F.A., Anthony J.C. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 2002, 26:479-488.
201. Waller M.B., et al. Effect of low dose ethanol on spontaneous motor activity in alcohol-preferring and -nonpreferring lines of rats. Pharmacology Biochemistry and Behavior 1986, 24:617-623.
202. Wheeler J.M., et al. Genetically correlated effects of selective breeding for high and low methamphetamine consumption. Genes, Brain and Behavior 2009, 8:758-771.
203. Whitfield J.B. Alcohol dehydrogenase and alcohol dependence: variation in genotype-associated risk between populations. American Journal of Human Genetics 2002, 71:1247-1250. (Author reply 1250-1241).
204. WHO, 1992. International statistical classification of diseases and related health problems 10th Revision (ICD-10). WHO, Geneva.
205. Wiley J.L., et al. Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats. Addiction Biology 2008, 13:277-286.
206. Yang A., et al. Genetics of caffeine consumption and responses to caffeine. Psychopharmacology 2010, 211:245-257.
207. 2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. American Journal of Physiology. Heart and Circulatory Physiology 2009, 296:H1141-H1149.
208. York J.L. The ethanol stimulus in rats with differing ethanol preferences. Psychopharmacology 1981, 74:339-343.
209. Zacny J.P., et al. Subjective and behavioral responses to intravenous fentanyl in healthy volunteers. Psychopharmacology 1992, 107:319-326.
210. Zacny J.P., et al. A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers. Journal of Pharmacology and Experimental Therapeutics 1994, 268:1-9.
211. Zacny J.P., Gutierrez S. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology 2003, 170:242-254.